CY1123382T1 - Απο του στοματος και ενεσιμα και σκευασματα ενωσεων τετρακυκλινης - Google Patents

Απο του στοματος και ενεσιμα και σκευασματα ενωσεων τετρακυκλινης

Info

Publication number
CY1123382T1
CY1123382T1 CY20201100908T CY201100908T CY1123382T1 CY 1123382 T1 CY1123382 T1 CY 1123382T1 CY 20201100908 T CY20201100908 T CY 20201100908T CY 201100908 T CY201100908 T CY 201100908T CY 1123382 T1 CY1123382 T1 CY 1123382T1
Authority
CY
Cyprus
Prior art keywords
injectable
oral
preparation
tetracycline compounds
compound
Prior art date
Application number
CY20201100908T
Other languages
English (en)
Inventor
Sean Johnston
Original Assignee
Paratek Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41114256&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1123382(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Paratek Pharmaceuticals, Inc. filed Critical Paratek Pharmaceuticals, Inc.
Publication of CY1123382T1 publication Critical patent/CY1123382T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Περιγράφονται ενέσιμα και από του στόματος σκευάσματα μιας ένωσης τετρακυκλίνης. Σε μία διαμόρφωση, η εφεύρεση αφορά σε ένα ενέσιμο σκεύασμα μιας ένωσης 9-αμινομεθυλοτετρακυκλίνης ή ενός άλατός της. Τα σκευάσματα μπορούν να χρησιμοποιούνται, για παράδειγμα, για τη θεραπεία λοιμώξεων.
CY20201100908T 2008-03-28 2020-09-24 Απο του στοματος και ενεσιμα και σκευασματα ενωσεων τετρακυκλινης CY1123382T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4039808P 2008-03-28 2008-03-28
PCT/US2009/001973 WO2009120389A1 (en) 2008-03-28 2009-03-30 Oral and injectable formulations of tetracycline compounds
EP09723896.8A EP2271348B1 (en) 2008-03-28 2009-03-30 Oral tablet formulation of tetracycline compound

Publications (1)

Publication Number Publication Date
CY1123382T1 true CY1123382T1 (el) 2021-12-31

Family

ID=41114256

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20181100542T CY1120240T1 (el) 2008-03-28 2018-05-23 Απο του στοματος χορηγουμενο παρασκευασμα δισκιου ενωσης τετρακυκλινης
CY20201100908T CY1123382T1 (el) 2008-03-28 2020-09-24 Απο του στοματος και ενεσιμα και σκευασματα ενωσεων τετρακυκλινης

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CY20181100542T CY1120240T1 (el) 2008-03-28 2018-05-23 Απο του στοματος χορηγουμενο παρασκευασμα δισκιου ενωσης τετρακυκλινης

Country Status (31)

Country Link
US (2) US9314475B2 (el)
EP (3) EP2271348B1 (el)
JP (7) JP2011515473A (el)
KR (3) KR101746228B1 (el)
CN (1) CN102046177B (el)
AU (1) AU2009229174A1 (el)
BR (2) BR122020011180B8 (el)
CA (2) CA2719751C (el)
CL (1) CL2010000281A1 (el)
CO (1) CO6300935A2 (el)
CY (2) CY1120240T1 (el)
DK (2) DK2271348T3 (el)
EC (1) ECSP10010576A (el)
ES (2) ES2836448T3 (el)
HK (1) HK1257928A1 (el)
HR (2) HRP20180836T1 (el)
HU (2) HUE038257T2 (el)
IL (1) IL208440A0 (el)
LT (2) LT2271348T (el)
MA (1) MA32275B1 (el)
MX (1) MX2010010585A (el)
NO (1) NO2271348T3 (el)
NZ (1) NZ588428A (el)
PL (2) PL2271348T3 (el)
PT (2) PT2271348T (el)
RU (1) RU2010144130A (el)
SI (2) SI3348258T1 (el)
TR (1) TR201806893T4 (el)
UA (2) UA122762C2 (el)
WO (1) WO2009120389A1 (el)
ZA (1) ZA201007013B (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009111064A2 (en) 2008-03-05 2009-09-11 Paratek Pharmaceuticals, Inc. Minocycline compounds and methods of use thereof
TW202021946A (zh) * 2008-05-23 2020-06-16 美商派洛泰克藥物股份有限公司 四環素化合物之甲苯磺酸鹽及同素異形體
RU2647972C2 (ru) 2010-05-12 2018-03-21 Ремпекс Фармацеутикалс, Инк. Тетрациклиновая композиция
AU2017259960A1 (en) * 2016-05-02 2018-12-06 Paratek Pharmaceuticals, Inc. 9-aminomethyl minocycline compounds and methods of use thereof in urinary tract infection (UTI) treatment
US10166912B2 (en) 2016-08-19 2019-01-01 Sl Corporation Automotive LED driving apparatus
US10383884B2 (en) 2016-11-01 2019-08-20 Paratek Pharmaceuticals, Inc. 9-aminomethyl minocycline compounds and use thereof in treating community-acquired bacterial pneumonia (CABP)
MX2021002503A (es) * 2018-09-04 2021-06-15 Paratek Pharm Innc Métodos de tratamiento de infecciones micobacterianas usando compuestos de tetraciclina.
PT117254B (pt) 2021-05-26 2024-04-18 Hovione Farm S A Método de síntese de compostos 9-aminometil tetraciclinas

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2699054A (en) * 1953-10-09 1955-01-11 Lloyd H Conover Tetracycline
US2712517A (en) * 1954-03-03 1955-07-05 Bristol Lab Inc Production of tetracycline and substituted tetracyclines
US3019173A (en) * 1956-06-04 1962-01-30 American Cyanamid Co Method for preparing tetracycline
US2990331A (en) 1956-11-23 1961-06-27 Pfizer & Co C Stable solutions of salts of tetracyclines for parenteral administration
US3005023A (en) * 1957-04-05 1961-10-17 American Cyanamid Co Production of tetracycline
US2980584A (en) 1957-10-29 1961-04-18 Pfizer & Co C Parenteral magnesium oxytetracycline acetic or lactic acid carboxamide vehicle preparation
US2886595A (en) * 1958-09-30 1959-05-12 Bristol Lab Inc Tetracycline recovery
US3062717A (en) 1958-12-11 1962-11-06 Pfizer & Co C Intramuscular calcium tetracycline acetic or lactic acid carboxamide vehicle preparation
US3019260A (en) * 1959-05-13 1962-01-30 American Cyanamid Co Process for the catalytic reduction of 6-hydroxy hydronaphthacenes
FR1430859A (el) * 1960-05-23 1966-05-25
US3165531A (en) 1962-03-08 1965-01-12 Pfizer & Co C 13-substituted-6-deoxytetracyclines and process utilizing the same
US3301899A (en) * 1963-11-27 1967-01-31 Bristol Myers Co Purification of tetracycline
US3454697A (en) 1965-06-08 1969-07-08 American Cyanamid Co Tetracycline antibiotic compositions for oral use
NL6607516A (el) 1966-05-31 1967-12-01
DE1767891C3 (de) 1968-06-28 1980-10-30 Pfizer Verfahren zur Herstellung von wäßrigen arzneilichen Lösungen für die parenterale, perorale und lokale Anwendung mit einem Gehalt an einem Tetracyclinderivat
US3957980A (en) 1972-10-26 1976-05-18 Pfizer Inc. Doxycycline parenteral compositions
DE2442829A1 (de) 1974-09-06 1976-03-18 Merck Patent Gmbh Tetracyclische verbindungen und verfahren zu ihrer herstellung
US4018889A (en) 1976-01-02 1977-04-19 Pfizer Inc. Oxytetracycline compositions
US4126680A (en) 1977-04-27 1978-11-21 Pfizer Inc. Tetracycline antibiotic compositions
US4837030A (en) * 1987-10-06 1989-06-06 American Cyanamid Company Novel controlled release formulations of tetracycline compounds
US5494903A (en) * 1991-10-04 1996-02-27 American Cyanamid Company 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
EP0536515B1 (en) 1991-10-04 2001-12-19 American Cyanamid Company Novel 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
US6465431B1 (en) * 1999-11-17 2002-10-15 Boston Life Sciences, Inc. Pharmaceutical compositions comprising troponin subunits, fragments and homologs thereof and methods of their use to inhibit angiogenesis
WO1999011261A1 (en) 1997-08-29 1999-03-11 Dsm N.V. Granules free of excipients
KR100252699B1 (ko) * 1998-03-17 2000-12-01 강재헌 치주염 치료용 미노사이클린 조성물
AU766200B2 (en) 1998-11-18 2003-10-09 Collagenex Pharmaceuticals, Inc. Novel 4-dedimethy laminotetra cycline derivatives
US6448323B1 (en) 1999-07-09 2002-09-10 Bpsi Holdings, Inc. Film coatings and film coating compositions based on polyvinyl alcohol
WO2001047554A1 (fr) * 1999-12-28 2001-07-05 Chugai Seiyaku Kabushiki Kaisha Compositions d'anticorps stables et preparations pour injection
KR100699390B1 (ko) * 2000-07-07 2007-03-28 트러스티즈 오브 터프츠 칼리지 9-치환된 미노사이클린 화합물
US7553828B2 (en) * 2001-03-13 2009-06-30 Paratek Pharmaceuticals, Inc. 9-aminomethyl substituted minocycline compounds
MXPA03008165A (es) 2001-03-13 2003-12-12 Paratek Pharm Innc Compuestos tetraciclina sustituidos en la posicion 7,9.
WO2002072031A2 (en) * 2001-03-14 2002-09-19 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds as synergistic antifungal agents
EP2311440A1 (en) * 2001-04-05 2011-04-20 Collagenex Pharmaceuticals, Inc. Controlled delivery of tetracycline compounds and tetracycline derivatives
US8088820B2 (en) * 2001-04-24 2012-01-03 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for the treatment of malaria
WO2003005971A2 (en) * 2001-07-13 2003-01-23 Paratek Pharmaceuticals, Inc. Tetracycline compounds having target therapeutic activities
EA200802365A1 (ru) * 2002-03-08 2009-08-28 Паратек Фармасьютикалс, Инк. Аминометилзамещенные тетрациклиновые соединения
CN1390550A (zh) * 2002-07-25 2003-01-15 于航 盐酸米诺环素冻干粉针剂及其制备方法
EP2277504A1 (en) * 2002-10-24 2011-01-26 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for the treatment of malaria
WO2004038000A2 (en) * 2002-10-24 2004-05-06 Paratek Pharmaceuticals, Inc. Methods of using substituted tetracycline compounds to modulate rna
US20040121003A1 (en) * 2002-12-19 2004-06-24 Acusphere, Inc. Methods for making pharmaceutical formulations comprising deagglomerated microparticles
WO2004064728A2 (en) * 2003-01-16 2004-08-05 Paratek Pharmaceuticals, Inc. Use of specific tetracycline compounds in therapy
KR20050105451A (ko) * 2003-02-03 2005-11-04 네오팜 인코포레이티드 안정한 멸균 여과가능한 리포좀 캡슐화 탁산 및 다른항종양제
WO2004078111A2 (en) 2003-03-06 2004-09-16 Ranbaxy Laboratories Limited Extended release minocycline compositions and processes for their preparation
WO2004091513A2 (en) * 2003-04-10 2004-10-28 Paratek Pharmaceuticals, Inc. 9-aminomethyl substituted minocycline compounds
US20060287283A1 (en) * 2003-07-09 2006-12-21 Paratek Pharmaceuticals, Inc. Prodrugs of 9-aminomethyl tetracycline compounds
AU2004259661B2 (en) * 2003-07-09 2011-11-10 Paratek Pharmaceuticals, Inc. Prodrugs of 9-aminomethyl tetracycline compounds
JP4733028B2 (ja) * 2003-07-09 2011-07-27 パラテック ファーマシューティカルズ インコーポレイテッド 置換テトラサイクリン化合物
EP1716101A1 (en) * 2004-01-15 2006-11-02 Paratek Pharmaceuticals, Inc. Aromatic a-ring derivatives of tetracycline compounds
GB2414668B (en) * 2004-06-03 2009-07-29 Dexcel Ltd Tetracycline modified release delivery system
KR101354093B1 (ko) * 2005-03-14 2014-01-24 와이어쓰 엘엘씨 티게사이클린 조성물 및 이의 제조방법
JP2009524675A (ja) * 2006-01-24 2009-07-02 パラテック ファーマシューティカルズ インコーポレイテッド テトラサイクリンの経口バイオアベイラビリティーを増加する方法
US20090246276A1 (en) * 2008-01-28 2009-10-01 Graham Jackson Pharmaceutical Compositions
WO2009111064A2 (en) * 2008-03-05 2009-09-11 Paratek Pharmaceuticals, Inc. Minocycline compounds and methods of use thereof

Also Published As

Publication number Publication date
EP3789030A1 (en) 2021-03-10
CN102046177B (zh) 2012-12-19
KR101835574B1 (ko) 2018-03-08
JP2023144043A (ja) 2023-10-06
WO2009120389A8 (en) 2009-12-30
JP2019196408A (ja) 2019-11-14
JP2018203778A (ja) 2018-12-27
BR122020011180B1 (pt) 2021-03-23
EP2271348A1 (en) 2011-01-12
JP6577645B2 (ja) 2019-09-18
CL2010000281A1 (es) 2012-03-30
LT2271348T (lt) 2018-06-25
JP2011515473A (ja) 2011-05-19
EP2271348A4 (en) 2011-05-25
BRPI0909211B8 (pt) 2021-05-25
CA2984301A1 (en) 2009-10-01
PL3348258T3 (pl) 2021-03-08
EP3348258A1 (en) 2018-07-18
AU2009229174A1 (en) 2009-10-01
SI3348258T1 (sl) 2020-12-31
MA32275B1 (fr) 2011-05-02
BRPI0909211A2 (pt) 2016-11-29
NZ588428A (en) 2012-08-31
HK1257928A1 (zh) 2019-11-01
JP2021167355A (ja) 2021-10-21
HUE052201T2 (hu) 2021-04-28
BR122020011180B8 (pt) 2021-07-27
HUE038257T2 (hu) 2018-10-29
BRPI0909211B1 (pt) 2020-08-25
NO2271348T3 (el) 2018-08-25
KR101893740B1 (ko) 2018-08-30
JP2014221820A (ja) 2014-11-27
PL2271348T3 (pl) 2018-08-31
IL208440A0 (en) 2010-12-30
HRP20180836T1 (hr) 2018-07-27
HRP20201883T1 (hr) 2021-01-22
WO2009120389A1 (en) 2009-10-01
EP2271348B1 (en) 2018-03-28
CY1120240T1 (el) 2019-07-10
KR20160105532A (ko) 2016-09-06
US20100056638A1 (en) 2010-03-04
SI2271348T1 (en) 2018-08-31
TR201806893T4 (tr) 2018-06-21
CA2719751A1 (en) 2009-10-01
CO6300935A2 (es) 2011-07-21
PT2271348T (pt) 2018-04-16
DK3348258T3 (da) 2020-12-07
KR101746228B1 (ko) 2017-06-12
KR20180026799A (ko) 2018-03-13
ES2836448T3 (es) 2021-06-25
DK2271348T3 (en) 2018-06-14
LT3348258T (lt) 2020-12-10
ECSP10010576A (es) 2010-12-30
UA109627C2 (uk) 2015-09-25
RU2010144130A (ru) 2012-05-10
MX2010010585A (es) 2010-11-09
CA2984301C (en) 2020-10-27
UA122762C2 (uk) 2021-01-06
ZA201007013B (en) 2013-11-27
JP5940119B2 (ja) 2016-06-29
KR20110008057A (ko) 2011-01-25
US20160279151A1 (en) 2016-09-29
US9314475B2 (en) 2016-04-19
PT3348258T (pt) 2020-11-25
EP3348258B1 (en) 2020-09-09
JP2016145260A (ja) 2016-08-12
JP6412521B2 (ja) 2018-10-24
ES2674708T3 (es) 2018-07-03
CN102046177A (zh) 2011-05-04
CA2719751C (en) 2018-01-02

Similar Documents

Publication Publication Date Title
CY1123382T1 (el) Απο του στοματος και ενεσιμα και σκευασματα ενωσεων τετρακυκλινης
CY1120031T1 (el) Αποπτωτικοι υποκινητες ν-ακυλοσουλφοναμιδης
CY1124855T1 (el) 2-(μορφολιν-4-υλ)-1,7-ναφθυριδινες
CY1122786T1 (el) Δοσολογικα σχηματα για ενωσεις κατηγοριας εχινοκανδινης
CY1124592T1 (el) Ζιζανιοκτονως δραστικα 3-φαινυλοïσοξαζολινο-5-καρβοξαμιδια αποτελουμενα απο τετραϋδρο- και διυδροφουρανοκαρβοξυλικα οξεα και εστερες
CY1122585T1 (el) Συνδυασμοι που περιλαμβανουν παραγωγα 5-φαινοξυ-3η-πυριμιδιν-4-ονης και η χρηση αυτων για την προφυλαξη ή αγωγη λοιμωξης απο ηiv
CY1121364T1 (el) Νεοι κυτταροστατικοι νουκλεοζιτες 7-δεαζαπουρινης
CY1122730T1 (el) 1,2,4-τριαζολες ως διαμορφωτες πυρηνικης μεταφορας και χρησεις αυτων
CY1118454T1 (el) Πρωτοτυποι αναστολεις πυρρολιου της αναγωγασης s-νιτροζογλουταθειονης ως θεραπευτικοι παραγοντες
CY1122853T1 (el) Σταθερα σκευασματα λινακλοτιδης
CY1117615T1 (el) Ενωσεις θειαζολης σουλφοναμιδης και οξαζολης
CY1121125T1 (el) Συνθεσεις για τη θεραπευτικη αντιμετωπιση του πονου και/ή της φλεγμονης
CY1118680T1 (el) Φαρμακευτικη συνθεση
CL2011000589A1 (es) Compuestos derivados de pirrolidin-2-carboxamida, inhibidores de la interaccion p53-mdm2; composicion farmaceutica que los comprende; y su uso en la preparacion de medicamentos utiles para el tratamiento del cancer.
HN2012001162A (es) Triazolopiridinas
CY1115751T1 (el) Φαρμακευτικος συνδυασμος 3-(3-διμεθυλαμινο-1-αιθυλ-2-μεθυλπροπυλ)-φαινολης και ενος αντιεπιληπτικου
EA201170772A1 (ru) Органические соединения
EA201170832A1 (ru) Пуриновые соединения
CY1115199T1 (el) Κυτταροτοξικοι παραγοντες που περιεχουν νεα παραγωγα τομαϋμυκινης και η θεραπευτικη τους χρηση
CY1115262T1 (el) Ανταγωνιστες trpv1 και χρησεις αυτων
CY1117118T1 (el) Φαρμακευτικος συνδυασμος για την αγωγη του πονου
EA201070278A1 (ru) Ингибиторы гамма-секретазы
GT200900201A (es) Formulaciones para el tratamiento del cáncer.
CY1122313T1 (el) Ορβεπιταντη για την αγωγη του χρονιου κνησμου
EA201270741A1 (ru) Пероральные композиции и липофильные соли метилналтрексона